Pharmacokinetics, Bioequivalence, and Spray Weight Reproducibility of Intranasal Butorphanol After Administration With 2 Different Nasal Spray Pumps

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of clinical pharmacology

• Publication date

  2005-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/0091270005278057PMID 16027409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Design and Analysis of Bioavailability and Bioequivalence Studies

  2003cited by this paper
• Characterization of Nasal Spray Pumps and Deposition Pattern in a Replica of the Human Nasal Airway

  2001cited by this paper
• Is the use of benzalkonium chloride as a preservative for nasal formulations a safety concern? A cautionary note based on compromised mucociliary transport.

  2000cited by this paper
• Design and Analysis of Bioavailability and Bioequivalence Studies

  1999cited by this paper
• Systemic availability of budesonide after nasal administration of three different formulations: pressurized aerosol, aqueous pump spray, and powder.

  1999cited by this paper
• Effects of physicochemical properties and other factors on systemic nasal drug delivery.

  1998cited by this paper
• Nasal delivery systems and their effect on deposition and absorption.

  1998cited by this paper
• The effect of a benzalkonium chloride-containing nasal spray on human respiratory mucosa in vitro as a function of concentration and time of action.

  1995cited by this paper
• Benzalkonium chloride in nasal decongestive sprays has a long‐lasting adverse effect on the nasal mucosa of healthy volunteers

  1995cited by this paper
• Multiple‐dose phase I study of transnasal butorphanol

  1993cited by this paper
• Nasal systemic drug delivery

  1989cited by this paper
• Deposition pattern of nasal sprays in man.

  1988cited by this paper
• Aerosol distribution in the nose.

  1978cited by this paper

• Effect of butorphanol nasal spray administration on patient cooperativity during labor epidural placement: a single-center randomized controlled trial

  2025cites this paper
• Butorphanol Tartrate Nasal Spray for Post-Cesarean Analgesia and Prolactin Secretion

  2024cites this paper
• Intranasal Atomized Dexmedetomidine in Combination with Intranasal Atomized Butorphanol for dressing change sedation and analgesia in adult burn patients: A Randomized Clinical Trial.

  2024cites this paper
• Intranasal drug delivery for treatment of Alzheimer’s disease

  2021cites this paper
• A current update on advanced drug delivery devices for nasal and pulmonary administration

  2021cites this paper
• Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges.

  2019cites this paper
• Patient-centered drug delivery and its potential applications for unmet medical needs.

  2017cites this paper
• Medicinski proizvodi namijenjeni nazalnoj primjeni lijekova

  2016cites this paper
• Intranasal delivery of rapid acting drugs : studies of pharmacokinetics, effect, tolerability, and satisfaction

  2013cites this paper
• Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review

  2012cites this paper
• Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids.

  2012cites this paper
• Determination of triamcinolone in human plasma by a sensitive HPLC-ESI-MS/MS method: application for a pharmacokinetic study using nasal spray formulation.

  2011cites this paper
• [Intranasal delivery of systemic drugs: a new route for opioid drugs].

  2010cites this paper
• Recent research trends in intranasal therapeutics - Select case studies of various therapeutic strategies with pharmacokinetic/pharmacodynamic attributes and drug development considerations

  2009cites this paper
• A review of the clinical pharmacokinetics of opioids, benzodiazepines, and antimigraine drugs delivered intranasally.

  2009cites this paper
• Asian Journal of Pharmacodynamics and Pharmacokinetics

  2009cites this paper
• Pharmacokinetics and interactions of headache medications, part I: introduction, pharmacokinetics, metabolism and acute treatments

  2006cites this paper